| Literature DB >> 34942391 |
Abstract
This issue of the Biomedical Journal provides a comprehensive insight into the role of pulmonary surfactant and influencing its components as well as involved molecules to treat a variety of respiratory distress disorders. We also discover how epithelial mesenchymal transition (EMT) could be targeted as part of a therapeutic strategy against lung cancer. Furthermore, a method is described to eliminate chemoresistance against gemcitabine, a drug administered to treat pancreatic cancer. We gain an insight into the composition of salivary calcium particles in periodontitis, a technique to circumvent complications in hip surgery, and a potential treatment to accelerate diabetic wound healing. Moreover, we get to know an essential oil that exerts a similar effect as diazepam on the central nervous system. A trial in patients with myofascial pain syndrome demonstrates how laser assisted trigger point therapy leads to immediate relief. Finally, a case study outlines the discovery of a genetic mutation that plays a role in intellectual disability.Entities:
Keywords: ARDS; Diabetic wound healing; Epithelial mesenchymal transition; Pancreatic cancer; Surfactant
Mesh:
Substances:
Year: 2021 PMID: 34942391 PMCID: PMC8847826 DOI: 10.1016/j.bj.2021.12.003
Source DB: PubMed Journal: Biomed J ISSN: 2319-4170 Impact factor: 4.910
Fig. 1The (dis-)balance between surfactant consumption and production in respiratory distress syndrome (RDS; with A = acute, P = pediatric, N = Neonatal) and pulmonary alveolar proteinosis (PAP) (Source: Luca et al. [9]).